Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Harvard Business School
McKinsey
Express Scripts
Baxter

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Cetuximab

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Cetuximab: Sponsors, patents, clinical trial progress

Cetuximab is an investigational drug.

There have been 753 clinical trials for Cetuximab. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2006.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Head and Neck Neoplasms, and Carcinoma, Squamous Cell. The leading clinical trial sponsors are National Cancer Institute (NCI), Bristol-Myers Squibb, and Merck KGaA.

Recent Clinical Trials for Cetuximab
TitleSponsorPhase
LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)AgendiaPhase 1/Phase 2
LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)Azienda Ospedaliera Niguarda Cà GrandaPhase 1/Phase 2
LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)Catalan Institute of HealthPhase 1/Phase 2

See all Cetuximab clinical trials

Clinical Trial Summary for Cetuximab

Top disease conditions for Cetuximab
Top clinical trial sponsors for Cetuximab

See all Cetuximab clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Medtronic
Express Scripts
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.